Researchers found that mice require significant external sensory cues to recognize changes in their reflection and can detect visual differences, but not tactile ones. The study identified a subset of neurons involved in developing self-image, highlighting the neural mechanisms behind self-recognition in mice.
Researchers from Japan have discovered a novel targeted molecular therapy using microRNA-451a to suppress the progression of gemcitabine-resistant biliary tract cancers. The study found that miR-451a significantly diminished cell proliferation, induced cell death, and reduced chemoresistance in cancer cells.
A study published at the Radiological Society of North America annual meeting found that higher amounts of visceral abdominal fat in midlife are associated with increased risk of Alzheimer's disease. The research also showed that this type of fat is linked to brain inflammation, which may contribute to the development of the disease.
Researchers have identified a specific microRNA molecule, miR-206, that plays a key role in atherosclerosis. By blocking its action, they were able to prevent the development of atherosclerotic lesions in mouse models and human cells. This discovery opens up new avenues for targeted therapies.
Researchers have identified a signaling pathway by which aspirin inhibits colorectal cancer. Aspirin induces the production of tumor-suppressive microRNA molecules miR-34a and miR-34b/c, necessary for mediating its anti-cancer effects.
Researchers discovered elevated miR-18a-5p expression in PCa patients with bone metastases, which inhibited osteoblast differentiation and activity. Inhibiting miR-18a-5p improved bone biomechanical properties and bone mineral mass in a mouse model.
Researchers found that cold exposure increases the secretion of miR-378a-3p by brown adipose tissue, which stimulates hepatic gluconeogenesis. This process is essential for regulating whole-body glucose homeostasis during cold stress.
Scientists developed a new method for detecting mid-infrared (MIR) light at room temperature using quantum systems. The MIR Vibrationally-Assisted Luminescence (MIRVAL) approach converts low-energy MIR photons into high-energy visible photons, enabling single-molecule spectroscopy and detection.
A new gene therapy study has identified microRNA-22 as a potential treatment for liver cancer, achieving better survival outcomes and reducing inflammation compared to the current FDA-approved drug lenvatinib. The treatment was administered via a single intravenous injection and showed no observable toxicity.
Researchers created an enhanced VCD sensing platform using chiral metamaterials to improve detection of chiral molecules in mixtures. The technology achieved a 6-magnitude enhancement and demonstrated high selectivity for protein secondary structures.
The FDA has issued a Biomarker Letter of Support for four novel biomarkers identifying drug-induced pancreatic injury. These microRNAs will enhance the detection of acute drug-induced pancreatic injury (DIPI) in phase 1 clinical trials, improving safety and accuracy.
Researchers at Northwestern University have discovered a way to soften stiff hair follicle stem cells, enabling them to grow hair again. By boosting the production of microRNA-205, they promote hair growth in both young and old mice, offering potential for human hair regrowth.
Researchers have developed a method to generate mid-infrared pulses with dual-wavelength spectral shaping, enabling flexible tunability in both temporal and spectral domains. This allows for enhanced High-Harmonic generation (HHG) control, opening new possibilities for applications such as electron dynamics and light-matter interaction.
Researchers at LMU identify curcumin as a potential treatment for colon cancer by activating the miR-34 pathway, which induces premature aging and programmed cell death. The substance also makes tumor cells more sensitive to chemotherapy.
Researchers at Brigham and Women's Hospital have identified a potential therapeutic target and developed a unique delivery system to treat osteosarcoma. MicroRNA nanoparticles delivered locally using a hydrogel suppressed osteosarcoma growth while decreasing bone damage.
Researchers have identified a potential therapeutic target and developed a unique delivery system to treat osteosarcoma, a bone cancer primarily affecting children and adolescents. The novel combination of gene therapy and chemotherapy may improve treatment outcomes and aid in the repair of damaged bones during chemotherapy.
Researchers found that miR-145 suppresses cervical cancer cell growth and inhibits aerobic glycolysis. Targeting miR-145 is expected to be an effective strategy for cervical cancer treatment, according to the study.
This study found that lncRNA TARL promotes the host's innate immune response by competing with TAK1 mRNA to bind miR-2188-3p, thereby helping fish resist Vibrio infection. Down-regulation of TAK1 expression improved bacterial escape efficiency.
A study has identified new microRNA biomarkers for the partial remission phase of type 1 diabetes and linked one of these microRNAs to immunoregulatory processes. The findings suggest a unique microRNA signature expression during this phase, which modulates regulatory T cell expansion and PD-1 expression.
Researchers at Baylor College of Medicine investigated neural crest cell development to better comprehend and treat craniofacial birth defects. They discovered that changes in chromatin accessibility are regulated by the miR-302 microRNA family, which can be used to generate healthy cells for regenerating craniofacial defects.
Researchers at Washington University in St. Louis have developed a non-invasive method called sonobiopsy that uses focused ultrasound to release neurodegenerative biomarkers into the blood, facilitating diagnosis of conditions like Alzheimer’s disease. The technique has shown promising results in releasing tau proteins and another biom...
A novel KRAS mutation promotes tumor evasion from innate immune surveillance by activating CD47, leading to decreased phagocytosis of cancer cells. Disruption of the KRAS-CD47 signaling axis with siRNA or inhibitors restores innate immune surveillance and enhances macrophage phagocytic capacity.
A team led by Abhinav Jha is developing a novel low-count quantitative single photon emission computed tomography (LC-QSPECT) method to measure the concentration of radiopharmaceutical material in tumors and vital organs. This technique aims to provide accurate measurements of absorbed dose from radiation therapy, helping plan treatmen...
A new MIR all-optical modulator based on an acetylene-filled hollow-core fiber has been developed, enabling gas sensing and medical diagnostics in the mid-infrared range. The device utilizes the photo-thermal effect to achieve phase modulation, allowing for ultra-broadband modulation devices from NIR to MIR.
Researchers discovered a microRNA biomarker, miR-145, can predict which breast cancer patients are at high risk of recurrence and death. This finding has the potential to identify tailored treatment options for these patients.
A new study found that small molecules in breast milk, specifically miR-375, can reduce the likelihood of infants developing allergic conditions like atopic dermatitis and food allergies. Infants who consumed more miR-375 had lower rates of these conditions, suggesting a potential protective effect of breast milk against allergies.
The NHS faces exceptional workforce issues due to Brexit and junior doctors' contract disputes, leading to a need for more international medical graduates. A proposed scheme to increase the cap on Tier 5 visas could help address these shortages and bring valuable expertise from countries like India and Nigeria.
A recent study found that microRNA-145 can identify breast cancer patients at lower risk of recurrence and those who may need additional therapy. The biomarker was measured in patients' blood samples during chemotherapy and predicted long-term oncological outcomes.
A chemically modified microRNA, miR-143#12, has been developed to target KRAS mutant cancers, demonstrating potent antiproliferative activity against colon cancer cell lines and significant tumor growth inhibition in mouse models. The microRNA suppresses the expression of key genes in the KRAS signaling network, inducing cell death at ...
A new type of spectrometer capable of simultaneous remote sensing of atmospheric methane, water vapor, and nitrous oxide has been developed. The spectrometer uses a micro-electro-mechanical system (MEMS) modulator to replace traditional mechanical choppers, making the system more stable and compact.
Researchers discovered that circVAPA modulates the miR-377-3p and miR-494-3p/IGF1R/AKT axis to promote SCLC progression. CircVAPA depletion enhances the inhibitory effects of an IGF1R kinase inhibitor, providing a potential therapeutic strategy.
The June issue of SLAS Discovery focuses on the role of microRNAs in cancer progression, particularly Kaposi’s sarcoma-associated herpes virus-derived miRNA K12-1. Researchers have also developed a new software workflow called Screener to automate data analysis from automated patch clamp electrophysiology platforms.
Researchers discovered a viral microRNA that induces the reactivation of human herpesvirus 6 (HHV-6), linked to impaired heart function and diseases like multiple sclerosis and ME/CFS. The miR-aU14 acts as a master regulator, interfering with cellular signaling pathways to trigger reactivation.
Researchers at CIC bioGUNE identified microRNA 873 as a potential therapeutic agent for acute liver failure due to APAP overdose. The study found that anti-miR-873-5p treatment rescues the liver and extends the therapeutic window by 24 hours.
Researchers provide a comprehensive survey on emerging RIS technology, discussing its promise and challenges in wireless communication systems. The technology offers unique features such as passive transmission and improved signal quality, but open problems remain to be solved.
Researchers have discovered a new sleep molecule, microRNA-137 (miR-137), that regulates hypocretin levels for normal sleep. The study found that miR-137 is associated with hypocretin regulation and sleep disorders such as narcolepsy and insomnia.
A study published in Cancer Medicine suggests that exosomes produced by adipose-derived mesenchymal stem cells can effectively deliver RNA-based anti-cancer treatments to bladder cancer tumors. This novel approach shows promise as a potential therapeutic agent for bladder cancer treatment, offering new hope for patients.
Researchers discovered a novel mechanism for miR-10b activation in high-grade gliomas, implicating topologic reorganization of chromatin and long-non-coding RNAs. This finding suggests new RNA-targeted strategies for glioma therapy and points to the vulnerability of tumor-initiating cells.
A recent study published in Molecular Therapy Nucleic Acids found that the molecule urocortin-2 may regulate recovery processes after a heart attack by modulating miR-29a. Treatment with urocortin-2 could favor patient recovery by regulating apoptosis and fibrosis.
Researchers at the University of Eastern Finland have developed a novel nuclear microRNA, miR-466c, that regulates vascular endothelial growth factor A (VEGFA) expression in response to hypoxia. The drug has commercial relevance for treating ischemic cardiovascular disease by increasing VEGFA levels.
Researchers found that miR-634 increases the effectiveness of oral squamous cell carcinoma treatment with cisplatin. The study suggests that applying a topical ointment containing miR-634 could be useful for enhancing chemotherapy effects in patients with advanced OSCC.
Researchers at Lund University have found a link between microRNA levels and insulin secretion in type 2 diabetes. By reducing the levels of miR-200c, they were able to increase insulin secretion in human cells.
Researchers have developed a lead-free ultra-broadband LED using lanthanide-doped double perovskites, offering improved stability and cost-effectiveness. The device shows promising applications in spectroscopic analysis and multifunctional lighting, outperforming previously reported ultrabroadband light sources.
Researchers at Brigham and Women's Hospital successfully differentiated vascular smooth muscle cells into endothelial cells using a miRNA cassette. The induced endothelial cells restored blood flow more quickly than conventional ECs in a murine hindlimb ischemia model.
Researchers at Brigham and Women's Hospital discovered a new function of miR-10b, interacting with U6 snRNA to alter global splicing in glioma cells. This study highlights the potential for miRNA-based treatments in cancer therapy.
A recent study published in Experimental Neurology suggests that the accumulation of a fragment of the synaptic protein neurexin in the adult brain causes specific losses of memory. The researchers observed that this accumulation triggers defects in associative memory and presynaptic plasticity, particularly affecting the amygdala.
Researchers at UT Southwestern Medical Center have developed a promising liver-specific microRNA drug that shows minimal toxicity in mice, preventing cancer cells from establishing themselves in the liver. The new treatment has potential as a candidate for companies developing mRNA vaccines for COVID-19.
Researchers analyzed thousands of space station photographs to discover that Russian cosmonauts use walls to display religious icons and Soviet heroes, reflecting national identity and cultural heritage. This study has practical applications for long-duration space missions, where understanding human identity and society is crucial.
A study reveals that blood biomarkers miR-137 and COX6A2 can distinguish between clinical sub-groups of patients with schizophrenia, offering a new tool for stratifying individuals and tailoring treatment. The discovery also highlights the critical role of oxidative stress in schizophrenia's heterogeneity.
A recent study has identified a new mechanism by which oral cancer cells acquire radioresistance through the transfer of microRNA, specifically miR-503-3p. This discovery brings hope for the development of new treatments for radiation-resistant oral cancer.
University of Adelaide scientists developed a new simple and inexpensive method to detect low concentrations of agricultural lime in soils. The Mid Infrared spectroscopy technique allows for accurate detection of very small amounts of lime, enabling farmers to manage their soils more effectively.
A new targeted nanomedicine treatment developed at the University of Chicago has shown promise in reducing vascular lesions caused by atherosclerosis. The treatment delivers medicine directly to inflamed cells, targeting the site of inflammation and inhibiting stenosis, the remodeling of vascular tissue that causes it to close off.
Researchers developed a novel biosensor using aptamer-combined SERS to detect miR-122 in cell-secreted exosomes, providing a potential biomarker for radiation-induced organ injury and liver inflammation. The method offers rapid separation of analytes using magnetic NPs, enabling early diagnosis of hepatic inflammation cases.
A study found that plasma cell-free miR-181c and tissue expression of miR-21, -210 accurately diagnose pancreatic adenocarcinoma (PA) with high accuracy. Further research is needed to validate its utility as a biomarker for PA diagnosis and monitoring.
Researchers discovered a microRNA, miR-766-5p, that targets super-enhancers and reduces MYC expression in cancer cells, inhibiting growth rates. The study suggests this molecule could be used as an anti-cancer therapeutic to fight MYC-driven cancers.
Researchers found that high CD39 expression is associated with human bladder cancer, particularly in the non-muscle-invasive phenotype. CD39's involvement in tumor development and progression is still unclear, but its overexpression in early-stage tumors suggests a potential role in bladder cancer progression.
A study in HNSC patients found that specific microRNAs, such as hsa-miR-203a-3p, mir-10a-5p, and miR-194-5p, are strongly associated with lymphovascular invasion (LVI). These miRNAs regulate biological pathways involved in tumor progression, making them potential prognostic indicators.
A new study from Salk Institute researchers found that a critical threshold of miR-218 levels determines the development of ALS in animal models. The study sheds light on the complex control of gene expression and its implications for treating neurological disorders.
A study published in Nature Communications found that microRNA-455 helps regulate cartilage homeostasis and slows cartilage degeneration in osteoarthritis. By targeting the gene hypoxia-inducible factor-2α, miR-455 treatment inhibits cartilage breakdown.
Researchers from Binghamton University and Harvard Medical School are using computer modeling and advanced imaging to study brain folding and growth in fetuses. They hope to understand the underlying mechanism of how brains form and how early weeks affect later life.